VITROS
- Primary DI
- 10758750034833
- Brand
- VITROS
- Company
- ORTHO CLINICAL DIAGNOSTICS
- Model
- 6177747
- Catalog number
- 6177747
- Device description
- VITROS Immunodiagnostic Products CA 19-9 Reagent Pack
- Published
- 2024-04-25
- Public version status
- New
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- true
Product Codes#
| Code | Name |
|---|---|
| NIG | SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| NIG | System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer | Immunology | 2 |
Premarket Submissions#
| Submission | Supplement |
|---|---|
| K231525 | 000 |
Premarket Details#
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 20758750034830 | Package | GS1 | 30 | In Commercial Distribution |
| 10758750034833 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized |
|---|---|
| 20758750034830 | 20758750034830 |
| 10758750034833 | 10758750034833 |
GMDN Terms#
| Term | Definition |
|---|---|
| Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay | A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 19-9 (CA19-9) in a clinical specimen, using a chemiluminescent immunoassay method. CA19-9 is typically used as a marker commonly associated with gastrointestinal, pancreatic, bile duct and gallbladder cancer. |
Storage And Handling#
| Type | Low | High | Condition |
|---|---|---|---|
| Special Storage Condition, Specify | 0 | 0 | Do not freeze |
| Storage Environment Temperature | 2 Degrees Celsius | 8 Degrees Celsius |
Regulatory Flags#
- DUNS number
- 215865786
- Device count
- 1
- Kit
- true
- Lot or batch
- true
- Expiration date on label
- true
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| 10758750033287 | VITROS | 6197735 | 6197735 | 2020-05-16 |
| 10758750033294 | VITROS | 6195575 | 6195575 | 2020-05-16 |
| 10758750032891 | VITROS | 6900040 | 6900040 | 2025-12-30 |
| 10758750033522 | VITROS | 6912232 | 6912232 | 2025-12-30 |
| 10758750033539 | VITROS | 6912233 | 6912233 | 2025-12-30 |
| 10758750008322 | VITROS | 1009406 | 1009406 | 2020-04-08 |
| 10758750002061 | VITROS | 6802156 | 6802156 | 2015-12-22 |
| 10758750002504 | VITROS | 6802301 | 6802301 | 2015-12-22 |
| 10758750035366 | VITROS | 6199454 | 6199454 | 2025-05-20 |
| 10758750035373 | VITROS | 6199455 | 6199455 | 2025-05-20 |
| 10758750035380 | VITROS | 6199456 | 6199456 | 2025-05-20 |
| 20758750035363 | VITROS | 6199454 | 6199454 | 2025-05-20 |
| 20758750035370 | VITROS | 6199455 | 6199455 | 2025-05-20 |
| 20758750035387 | VITROS | 6199456 | 6199456 | 2025-05-20 |
| 10758750000203 | VITROS | 1896836 | 1896836 | 2016-08-26 |
| 10758750002801 | VITROS | 6802454 | 6802454 | 2014-10-22 |
| 10758750035465 | VITROS | 6174442 | 6174442 | 2023-11-22 |
| 10758750034420 | VITROS | 6199961 | 6199961 | 2021-11-08 |
| 10758750033355 | VITROS | 6199919 | 6199919 | 2021-03-22 |
| 10758750033362 | VITROS | 6199920 | 6199920 | 2021-03-22 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| 07613336218341 | Elecsys CA 19-9 | Roche Diagnostics GmbH | NIG | 2026-06-01 |
| 20758750034830 | VITROS | ORTHO CLINICAL DIAGNOSTICS | NIG | 2024-04-25 |
| 00630414293516 | Atellica IM CA 19-9 | Siemens Healthcare Diagnostics Inc. | NIG | 2020-05-31 |
| 14560189213392 | ST AIA-PACK PROG II | TOSOH CORPORATION | NIG | 2019-07-12 |
| 00816870020518 | CA 19-9 AccuBind ELISA Test System - 96 Wells | MONOBIND, INC. | NIG | 2019-02-11 |
| 00816870020525 | CA 19-9 AccuBind ELISA Test System - 192 Wells | MONOBIND, INC. | NIG | 2019-02-11 |
| 00816870022192 | CA 19-9 AccuLite CLIA Test System - 96 Wells | MONOBIND, INC. | NIG | 2019-02-11 |
| 00816870022208 | CA 19-9 AccuLite CLIA Test System - 192 Wells | MONOBIND, INC. | NIG | 2019-02-11 |
| 00380740155919 | Alinity | Abbott GmbH | NIG | 2019-01-03 |
| 00630414577135 | ADVIA Centaur® CA 19-9 DIL | Siemens Healthcare Diagnostics Inc. | NIG | 2018-12-01 |
| 00630414598161 | Atellica IM CA 19-9 | Siemens Healthcare Diagnostics Inc. | NIG | 2018-02-06 |
| 00380740137304 | ARCHITECT | Abbott GmbH | NIG | 2017-12-29 |
| 00630414598192 | Atellica IM CA 19-9 MCM | Siemens Healthcare Diagnostics Inc. | NIG | 2017-12-27 |
| 00630414598178 | Atellica IM CA 19-9 | Siemens Healthcare Diagnostics Inc. | NIG | 2017-12-22 |
| 00630414598185 | Atellica IM CA 19-9 DIL | Siemens Healthcare Diagnostics Inc. | NIG | 2017-12-22 |
| 00380740145392 | ARCHITECT | Abbott GmbH | NIG | 2017-05-01 |
| 00380740145408 | ARCHITECT | Abbott GmbH | NIG | 2017-05-01 |
| 04015630939640 | Elecsys CA 19-9 | Roche Diagnostics GmbH | NIG | 2017-04-14 |
| 14560189210209 | ST AIA-PACK CA 19-9 | TOSOH CORPORATION | NIG | 2016-09-24 |
| 04560189211124 | AIA-PACK CA 19-9 Sample Diluting Solution | TOSOH CORPORATION | NIG | 2016-09-24 |
| 00842768028533 | Dimension Vista® Flex® reagent cartridge CA19-9 | Siemens Healthcare Diagnostics Inc. | NIG | 2016-09-24 |
| 00630414447926 | ADVIA Centaur® CA 19-9 MCM | Siemens Healthcare Diagnostics Inc. | NIG | 2016-09-24 |
| 00630414574028 | ADVIA Centaur® CA 19-9™ | Siemens Healthcare Diagnostics Inc. | NIG | 2016-09-24 |
| 00630414574257 | ADVIA Centaur® CA 19-9™ | Siemens Healthcare Diagnostics Inc. | NIG | 2016-09-24 |
| 00630414577128 | ADVIA Centaur® CA 19-9™ DIL | Siemens Healthcare Diagnostics Inc. | NIG | 2016-09-24 |
| 04015630904297 | Elecsys CA 199 Immunoassay | Roche Diagnostics GmbH | NIG | 2016-09-20 |
| 15099590231842 | Access GI Monitor | Beckman Coulter, Inc. | NIG | 2016-09-09 |
| 10758750002351 | VITROS | ORTHO CLINICAL DIAGNOSTICS | NIG | 2016-08-26 |
| 00380740003555 | ARCHITECT | ABBOTT LABORATORIES | NIG | 2016-06-06 |
| 00380740003562 | ARCHITECT | ABBOTT LABORATORIES | NIG | 2016-06-06 |